Answer
Ramucirumab is contraindicated in patients with non-small cell lung cancer when there is tumour cavitation or tumour involvement of major vessels.
Sources for this answer
- Cyramza 10 mg/ml concentrate for solution for infusionEli Lilly and Company Limited · emc · SmPC §4.3 Contraindications · Version 18Document updated
Sources checked